This announcement is a separate document:
康泰生物：深圳康泰生物制品股份有限公司向不特定对象发行可转换公司债券受托管理事务报告（2023年度）
Shenzhen Kangtai Biological Products: Shenzhen Kangtai Biological Products Co., Ltd. issued a trust management report on convertible corporate bonds (2023) to unspecified parties.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.